NABLA BIO Trademark

Trademark Overview

On Tuesday, March 14, 2023, a trademark application was filed for NABLA BIO with the United States Patent and Trademark Office. The USPTO has given the NABLA BIO trademark a serial number of 97839207. The federal status of this trademark filing is REVIVED - AWAITING FURTHER ACTION as of Saturday, July 12, 2025. This trademark is owned by Nabla Bio, Inc.. The NABLA BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the field of biotechnology and pharmaceutical products; Research and development in the field of discovery, design, synthesis and characterization of biomolecules; Scientific research consulting in the field of biotechnology and pharmaceutical products; Scientific research in the field of biotechnology and pharmaceutical products; Scientific and technological services, namely, design, engineering, research, development and testing in the field of biological and pharmaceutical products, synthesis, and customization for medical, scientific, and technological applications; Scientific and technological services, namely, design, engineering, research, development and testing in the field of biological and pharmaceutical products, synthesis, and customization for medical, and scientific applications; Providing scientific research information in the field of in silico discovery and design of biological and pharmaceutical products

General Information

Serial Number97839207
Word MarkNABLA BIO
Filing DateTuesday, March 14, 2023
Status616 - REVIVED - AWAITING FURTHER ACTION
Status DateSaturday, July 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 26, 2024

Trademark Statements

NOT AVAILABLEBIO
Goods and ServicesResearch and development in the field of biotechnology and pharmaceutical products; Research and development in the field of discovery, design, synthesis and characterization of biomolecules; Scientific research consulting in the field of biotechnology and pharmaceutical products; Scientific research in the field of biotechnology and pharmaceutical products; Scientific and technological services, namely, design, engineering, research, development and testing in the field of biological and pharmaceutical products, synthesis, and customization for medical, scientific, and technological applications; Scientific and technological services, namely, design, engineering, research, development and testing in the field of biological and pharmaceutical products, synthesis, and customization for medical, and scientific applications; Providing scientific research information in the field of in silico discovery and design of biological and pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 4, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNabla Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNabla Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Friday, March 17, 2023NEW APPLICATION ENTERED
Tuesday, April 4, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 11, 2023ASSIGNED TO EXAMINER
Tuesday, December 12, 2023NON-FINAL ACTION WRITTEN
Tuesday, December 12, 2023NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 12, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, March 12, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, June 12, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, June 12, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, June 12, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 12, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 12, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 29, 2024FINAL REFUSAL WRITTEN
Monday, July 29, 2024FINAL REFUSAL E-MAILED
Monday, July 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, September 10, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 10, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 29, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, September 10, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, October 29, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, October 29, 2024EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, October 30, 2024EXPARTE APPEAL TERMINATED
Wednesday, November 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, July 12, 2025PETITION TO REVIVE-GRANTED
Saturday, July 12, 2025NOTICE OF REVIVAL - E-MAILED
Saturday, July 12, 2025TEAS PETITION TO REVIVE RECEIVED
Saturday, July 12, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 26, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 26, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

nabla research field scientific products pharmaceutical development design technological biological biotechnology